GeoVax Labs, Inc.
GeoVax Labs, Inc. (GOVX): 5 pipeline candidates · ~1 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.4 months
D/E 5.04 · 0% dilution
Lead: Phase 3
5 candidates
N/A
N/A
A transparent, data-derived signal for GeoVax Labs, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$6.0M
Cash
$1.3M
Quarterly Burn
$3.5M
Runway
1.4 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| covid-19 vaccine | Phase 2 |
| gedeptin | Phase 2 |
| geo-cm04s1 | Phase 2 |
| geo-mva | Phase 3 |
| synthetic mva-based sars-cov-2 vaccine geo-cm04s1 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
12
Total value held
$439K
| Holder | Shares | Value |
|---|---|---|
| armistice capital, llc | 269,253 | $372K |
| geode capital management, llc | 36,076 | $50K |
| vanguard capital management llc | 6,434 | $9K |
| vanguard fiduciary trust co | 5,068 | $7K |
| blackrock, inc. | 1,093 | $2K |
| wells fargo & company/mn | 31 | $43 |
| morgan stanley | 6 | $8 |
| danske bank a/s | 3 | $4 |
| caitong international asset management co., ltd | 2 | $3 |
| quaker wealth management, llc | 1 | $2 |
Showing top 10 of 12 institutional holders of GeoVax Labs, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in GeoVax Labs, Inc.'s pipeline?
GeoVax Labs, Inc. (GOVX) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is GeoVax Labs, Inc.'s lead drug candidate?
GeoVax Labs, Inc.'s most advanced tracked candidate is covid-19 vaccine (Phase 2) for COVID-19 Infection.
What is GeoVax Labs, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, GeoVax Labs, Inc. has approximately 1.4 months of cash runway.
What is GeoVax Labs, Inc.'s market capitalization?
GeoVax Labs, Inc.'s market capitalization is approximately $6.0M.
Who is the CEO of GeoVax Labs, Inc.?
Mr. David Alan Dodd is the chief executive officer of GeoVax Labs, Inc. (GOVX).
Get the full picture on GeoVax Labs, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.